Remove Acquisition Remove Blogging Remove Report Remove San Diego
article thumbnail

San Diego Innovation Economy Extended Gains in 2015: Connect Report

Xconomy

San Diego’s innovation clusters continued to grow in 2015, as local startups, funding deals, and job growth extended an economic growth spurt that began in 2013. That’s according to a report being released today by Connect, the local nonprofit group focused on technology and entrepreneurship.

article thumbnail

Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup

Xconomy

San Diego-based Ligand (NASDAQ: LGND ) generates revenue from licensing deals and royalties paid by pharmaceutical companies that use technologies it develops or acquires for their own drug research. The company reported revenues of about $120.3 million in 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Third-Quarter Report Shows Slowdown in VC Activity, & Top 10 Deals

Xconomy

Venture capital activity is gradually easing from last year’s peak, according to a new quarterly report put together by Seattle-based PitchBook and the National Venture Capital Association. deals (1,796 companies) during the third quarter that ended September 30, according to the inaugural “Venture Monitor” report released today.

article thumbnail

Reflections on 2018: Andy Wilson, Alliance for SoCal Innovation

socalTECH

In my new role as the first executive director for the Alliance for Southern California Innovation, I spent a lot of time outside of my home turf of Pasadena -- visiting innovation nodes such as San Diego, Irvine, Riverside, Santa Barbara, Venice, Santa Monica, and others. What was the biggest news for your organization in 2018?

article thumbnail

Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

Xconomy

Pernix Therapeutics is slashing its headcount by more than 20 percent as the specialty pharmaceutical company tries to move toward profitability after a streak of acquisitions. As of the end of 2015, Pernix reported a headcount of 274. In 2014, Pernix, then based in The Woodlands, TX, acquired San Diego-based Somaxon Pharmaceuticals.

Sales 40
article thumbnail

Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More

Xconomy

Is one of the bigger biopharma acquisitions of the year in trouble? As Reuters reports, Roche and Spark remain committed to the. This past week, antitrust regulators once again delayed Roche’s planned $4.8 billion buyout of gene therapy developer Spark Therapeutics (NASDAQ: ONCE ). Yet the deal has now been pushed back four times.

News 97
article thumbnail

LabCorp Boosts Prenatal Testing Presence with $371M Sequenom Deal

Xconomy

LabCorp will also assume net debt of San Diego-based Sequenom (NASDAQ: SQNM ), bringing the value of the cash deal to approximately $371 million. LabCorp reported $8.5 Despite the fanfare of Sequenom’s MaterniT21, the company has had financial struggles and its earnings reports show a history of losses.